Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells

Lung cancer is one of the leading causes of cancer-associated mortality, worldwide. The overall survival rate remains low, but progress has been made in improving the diagnosis and treatment of lung cancer over the past decades. Niclosamide, a salicylanilide derivative used for the treatment of tape...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Mei, Chen, Zihong, Yang, Donghong, Li, Haiwen, Zuo, Yufang, Li, Jingjing, Zhang, Wendian, Zhou, Hechao, Jiang, Danxian, Xu, Zumin, Yu, Zhonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530112/
https://www.ncbi.nlm.nih.gov/pubmed/28781637
http://dx.doi.org/10.3892/ol.2017.6372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530112/
https://www.ncbi.nlm.nih.gov/pubmed/28781637
http://dx.doi.org/10.3892/ol.2017.6372

Ejemplares similares